Cannot agree with you more JJ. CFS diagnose process is an exclusion process. Any fatigue that cannot be linked to known problems and has lasted more than 6 months will be taken as CFS. That is why in US, there are 5 milion CFS patients. to be honest, these 5 million patients could be from 100 different illnesses.
Thought FDA is going to loose the stringent requirements for both clinical and statistical evidence this time since the agency knows AMP cannot treat all the CFS patients. In the 2009 CRL, there was a request for another trial that covers the "targeted population". Aparently, FDA is not comfortable for approving the drug for CFS patients as it is defined today.
Sold yesterday as a loss. Bought ALXA at $5.5. Hope I can break even after this weekend.